|
NOL6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5883999999744E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.604700E-04 |
| Normal-vs-Stage2 |
2.857600E-02 |
| Normal-vs-Stage3 |
4.176300E-03 |
| Normal-vs-Stage4 |
4.605900E-02 |
| Stage1-vs-Stage2 |
7.133400E-01 |
| Stage1-vs-Stage3 |
1.907820E-01 |
| Stage1-vs-Stage4 |
5.177600E-01 |
| Stage2-vs-Stage3 |
4.486600E-01 |
| Stage2-vs-Stage4 |
7.544400E-01 |
| Stage3-vs-Stage4 |
7.367200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30180000000613E-05 |
| Normal-vs-AfricanAmerican |
3.966900E-04 |
| Normal-vs-Asian |
1.857390E-01 |
| Caucasian-vs-AfricanAmerican |
8.884600E-01 |
| Caucasian-vs-Asian |
6.812000E-01 |
| AfricanAmerican-vs-Asian |
5.625000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.3278000000081E-06 |
| Normal-vs-Female |
6.204700E-04 |
| Male-vs-Female |
8.033400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.829900E-04 |
| Normal-vs-Extreme_Weight |
4.369300E-04 |
| Normal-vs-Obese |
1.156750E-03 |
| Normal-vs-Extreme_Obese |
1.336770E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.333800E-01 |
| Normal_Weight-vs-Obese |
7.448200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.252200E-01 |
| Extreme_Weight-vs-Obese |
5.767200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.903400E-01 |
| Obese-vs-Extreme_Obese |
7.876600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.667770E-02 |
| Normal-vs-Age(41-60Yrs) |
2.41359999986202E-07 |
| Normal-vs-Age(61-80Yrs) |
1.641050E-03 |
| Normal-vs-Age(81-100Yrs) |
6.797800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.662200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.202200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.906100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.094190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.708400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.619200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.09780000055049E-07 |
| Normal-VS-Type2 PRCC |
1.357790E-01 |
| Normal-VS-KIRP CIMP |
9.036900E-03 |
| Normal-VS-Unclassified PRCC |
8.143400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.851550E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.674200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.274600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.891550E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.473000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.726400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.699400E-03 |
| Normal-vs-N1 |
5.094300E-02 |
| Normal-vs-N2 |
4.893200E-01 |
| N0-vs-N1 |
4.805600E-01 |
| N0-vs-N2 |
6.546600E-01 |
| N1-vs-N2 |
5.729400E-01 |
|
|
